RT Journal Article
SR Electronic
T1 Asymmetric anti-CLL-1×CD3 bispecific antibody, ABL602 2+1, with attenuated CD3 affinity endows potent antitumor activity but limited cytokine release
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e007494
DO 10.1136/jitc-2023-007494
VO 11
IS 10
A1 Lee, Eunhee
A1 Lee, Shinai
A1 Park, Sumyeong
A1 Son, Yong-Gyu
A1 Yoo, Jiseon
A1 Koh, Youngil
A1 Shin, Dong-Yeop
A1 Lim, Yangmi
A1 Won, Jonghwa
YR 2023
UL http://jitc.bmj.com/content/11/10/e007494.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.